Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 3:11:922.
doi: 10.3389/fmicb.2020.00922. eCollection 2020.

Identification by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Testing of Non- Aspergillus Molds

Affiliations

Identification by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Testing of Non- Aspergillus Molds

Ying Li et al. Front Microbiol. .

Abstract

Non-Aspergillus molds including Mucorales, Fusarium, and Scedosporium, etc. are emerging pathogens leading to higher mortality in immunocompromised patients. Fifty-two isolates of genetically confirmed non-Aspergillus molds representing 16 species from 8 genera were collected to evaluate the performance of the Bruker matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in identification of non-Aspergillus molds. Antifungal susceptibilities were determined through the Clinical & Laboratory Standards Institute (CLSI) M38-A2 broth microdilution method and the Sensititre YeastOne colorimetric method. Bruker MALDI-TOF MS identified 57.7% (30/52) of isolates cultured in broth and 15.4% (8/52) of isolates cultured on solid agar media to the species level, respectively, according to standard interpretation criteria. Lowering the species level cut-off value (COV) from ≥2.0 to ≥1.7 could improve the MALDI-TOF MS species-level identification rate to 67.3% (38/52) for isolates cultured on solid media, with a slight increase of false identification rate of 2.6% (1/38). Amphotericin B was the most in vitro fungistatic-active agent for 98.1% (51/52) of the tested non-Aspergillus molds, with minimum inhibitory concentrations (MICs) of ≤2 μg/mL. The susceptibilities to triazoles varied, with MICs of 0.12 to >16 μg/mL among different species of non-Aspergillus molds. The correlation between the CLSI method and Sensititre YeastOne on antifungal susceptibility testing of non-Aspergillus molds was good, with essential agreement (EA) rates of >90% for triazoles and echinocandins except amphotericin B, which had a lower EA rate of 84.6%. In conclusion, a favorable performance of the Bruker MALDI-TOF MS in identification of clinical non-Aspergillus isolates directly inoculated on solid agar media could be achieved with the adoption of alternative interpretation criteria. Antifungal susceptibility testing is important for non-Aspergillus molds, especially when information on triazole susceptibility is required, and the Sensititre YeastOne is a practical and reliable method to determine antifungal susceptibilities of non-Aspergillus molds.

Keywords: MALDI-TOF MS; Sensititre YeastOne; antifungal susceptibility testing; identification; non-Aspergillus molds.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Alanio A., Beretti J. L., Dauphin B., Mellado E., Quesne G., Lacroix C., et al. (2010). Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin. Microbiol. Infect. 17 750–755. 10.1111/j.1469-0691.2010.03323.x - DOI - PubMed
    1. Carrillo-Muñoz A. J., Quindós G., Ruesga M., del Valle O., Pemán J., Cantón E., et al. (2006). In vitro antifungal susceptibility testing of filamentous fungi with sensititre yeast one. Mycoses 49 293–297. 10.1111/j.1439-0507.2006.01250.x - DOI - PubMed
    1. Cassagne C., Normand A. C., L’Ollivier C., Ranque S., Piarroux R. (2016). Performance of MALDI-TOF MS platforms for fungal identification. Mycoses 8 678–690. 10.1111/myc.12506 - DOI - PubMed
    1. Delavy M., Dos Santos A. R., Heiman C. M., Coste A. T. (2019). Investigating antifungal susceptibility in Candida species with MALDI-TOF MS-based assays. Front. Cell. Infect. Microbiol. 9:19. 10.3389/fcimb.2019.00019 - DOI - PMC - PubMed
    1. Douglas A. P., Chen S. C., Slavin M. A. (2016). Emerging infections caused by non-Aspergillus filamentous fungi. Clin. Microbiol. Infect. 22 670–680. 10.1016/j.cmi.2016.01.011 - DOI - PubMed

LinkOut - more resources